The results of this study show that Escin significantly decreased the growth of human pancreatic carcinoma cells, inhibited NF-κB signaling pathways, and sensitized pancreatic cancer cells to the cytotoxic effect of chemotherapy. Here, NFKB1 is linked to familial pancreatic carcinoma.